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Background
Tunneling nanotubes (TNT) are cytoskeletal bridges that
support intercellular exchanges of receptors, lysosomes
and mitochondria. HIV-1 transmission by intercellular
connections such as TNT and immunological synapses
may facilitate cellular transmission when compared to
classical receptor-mediated mechanisms. This permits for
acactive viral spread despite neutralizing antibodies.
Mechanisms of TNT formation and pathogen immune
escape through TNT transport have generated intense
interest after failure of vaccination strategies.
Methods
To determine the mechanisms underlying the formation
of TNT and intra- and intercellular viral trafficking we
used still and time lapse confocal imaging, transmission
and scanning electron microscopy, antibodies to and
chemical inhibitors of motor and cytoskeletal proteins.
Proteomics techniques were sued to assist in determining
the biochemical composition of TNT as well as the type of
vesicular cargoes adopted for viral transport along these
structures.
Results
We now demonstrate that HIV-1-infected human mono-
cyte-derived macrophages (MDM) can establish direct
cell-cell contacts via the TNT networks. In parallel to struc-
tural organization HIV-1 induces an increase in vesicle
sorting and turnover. Co-cultivation of uninfected and
infected cells resulted in formation of intercellular con-
tacts extending over 700 μm in length. Electron and con-
focal microscopy revealed the tubular nature of TNT
tethered at the perinuclear/Golgi regions of the connected
cells, and rich in vesicular compartments confined by the
TNT limiting membranes. Accumulation of adherence
junction components along the TNT at the contact sites
was observed. Use of cytoskeleton-disrupting drugs such
as cytochalsin D, nocodasole indicated a critical role for
actin in driving TNT formation. Proteomic analysis of TNT
collected from infected cells showed substantial presence
of early, late and recycling endosomes together with vesi-
cle trafficking components including Rab GTP-ase family
proteins (Rab2a/5a/7, 11) and myosins along the TNT.
Proteomic analysis identified HIV-1 proteins including
HIV-1 Tat, Rev, Gag and gp120 along TNT. Confocal
imaging showed TNT support active and bi-directional
vesicle exchange at an average velocity of 1.5 μm/s. These
events are accompanied with significant co-localisation of
Env and Gag proteins with vesicle-cargo motor proteins
and actively transported from the infected to uninfected
target cells. Inhibition of myosin II by blebbistatin and
butandiene monoxime together with use of cytochalasin
D/nocodasole completely abrogated movement of HIV+
vesicles along the TNT.
Conclusion
These data provide new evidence that HIV-1 may escape
immune surveillance and neutralizing antibodies by
inducing both structural rearrangements (TNT formation)
and membrane turnover (increased vesicle sorting) in
human macrophages and uses such processes for direct
transport from infected to the target uninfected cells.
from Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts
Montpellier, France. 21-23 September 2009
Published: 24 September 2009
Retrovirology 2009, 6(Suppl 2):O22 doi:10.1186/1742-4690-6-S2-O22
<supplement> <title> <p>Frontiers of Retrovirology: Complex retroviruses, retroelements and their hosts</p> </title> <note>Meeting abstracts - A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1742-4690-6-S2-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1742-4690-6-S2-info.pdf</url> </supplement>
This abstract is available from: http://www.retrovirology.com/content/6/S2/O22
© 2009 Kadiu et al; licensee BioMed Central Ltd. 